

Cover Story
COVID-19 & CancerFreeGuest Editorial
Cancer patients and survivors should not get COVID-19. A three-time cancer survivor should definitely not get COVID. But I did. And it was not good. Here is my story and the lessons I learned that might be of value to others.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for Jan. 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation
- Anthony Letai sworn in as 18th NCI director
- Trump backs off the 100% pharma tariffs ultimatum
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - The evolution of cellular immunotherapy: From transplant to CAR T cells